Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.

Ross RA.

Trends Pharmacol Sci. 2011 May;32(5):265-9. doi: 10.1016/j.tips.2011.01.005. Epub 2011 Mar 1.

PMID:
21367464
2.

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.

Piñeiro R, Maffucci T, Falasca M.

Oncogene. 2011 Jan 13;30(2):142-52. doi: 10.1038/onc.2010.417. Epub 2010 Sep 13.

PMID:
20838378
3.

Lysophosphatidylinositol signalling: new wine from an old bottle.

Piñeiro R, Falasca M.

Biochim Biophys Acta. 2012 Apr;1821(4):694-705. doi: 10.1016/j.bbalip.2012.01.009. Epub 2012 Jan 20. Review.

PMID:
22285325
4.

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.

Ford LA, Roelofs AJ, Anavi-Goffer S, Mowat L, Simpson DG, Irving AJ, Rogers MJ, Rajnicek AM, Ross RA.

Br J Pharmacol. 2010 Jun;160(3):762-71. doi: 10.1111/j.1476-5381.2010.00743.x.

5.

The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.

Yamashita A, Oka S, Tanikawa T, Hayashi Y, Nemoto-Sasaki Y, Sugiura T.

Prostaglandins Other Lipid Mediat. 2013 Dec;107:103-16. doi: 10.1016/j.prostaglandins.2013.05.004. Epub 2013 May 25. Review.

PMID:
23714700
6.

2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.

Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T.

J Biochem. 2009 Jan;145(1):13-20. doi: 10.1093/jb/mvn136. Epub 2008 Oct 9.

PMID:
18845565
7.

What is the natural ligand of GPR55?

Okuno T, Yokomizo T.

J Biochem. 2011 May;149(5):495-7. doi: 10.1093/jb/mvr022. Epub 2011 Feb 15.

PMID:
21324983
8.

Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors.

Ruban EL, Ferro R, Arifin SA, Falasca M.

Biochem Soc Trans. 2014 Oct;42(5):1372-7. doi: 10.1042/BST20140151. Review.

PMID:
25233417
9.

Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.

Obara Y, Ueno S, Yanagihata Y, Nakahata N.

PLoS One. 2011;6(8):e24284. doi: 10.1371/journal.pone.0024284. Epub 2011 Aug 31.

10.

The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.

Moreno-Navarrete JM, Catalán V, Whyte L, Díaz-Arteaga A, Vázquez-Martínez R, Rotellar F, Guzmán R, Gómez-Ambrosi J, Pulido MR, Russell WR, Imbernón M, Ross RA, Malagón MM, Dieguez C, Fernández-Real JM, Frühbeck G, Nogueiras R.

Diabetes. 2012 Feb;61(2):281-91. doi: 10.2337/db11-0649. Epub 2011 Dec 16.

11.

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ.

FASEB J. 2009 Jan;23(1):183-93. doi: 10.1096/fj.08-108670. Epub 2008 Aug 29.

12.

Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.

Oka S, Kimura S, Toshida T, Ota R, Yamashita A, Sugiura T.

J Biochem. 2010 May;147(5):671-8. doi: 10.1093/jb/mvp208. Epub 2010 Jan 4.

PMID:
20051382
13.

The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.

Kallendrusch S, Kremzow S, Nowicki M, Grabiec U, Winkelmann R, Benz A, Kraft R, Bechmann I, Dehghani F, Koch M.

Glia. 2013 Nov;61(11):1822-31. doi: 10.1002/glia.22560. Epub 2013 Sep 3.

PMID:
24038453
14.

GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?

Nevalainen T, Irving AJ.

Curr Top Med Chem. 2010;10(8):799-813. Review.

PMID:
20370712
15.

Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.

Anavi-Goffer S, Baillie G, Irving AJ, Gertsch J, Greig IR, Pertwee RG, Ross RA.

J Biol Chem. 2012 Jan 2;287(1):91-104. doi: 10.1074/jbc.M111.296020. Epub 2011 Oct 25.

16.

A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse G-protein signalling pathways in sensory nerves in vivo.

Gangadharan V, Selvaraj D, Kurejova M, Njoo C, Gritsch S, Škoricová D, Horstmann H, Offermanns S, Brown AJ, Kuner T, Tappe-Theodor A, Kuner R.

Pain. 2013 Dec;154(12):2801-12. doi: 10.1016/j.pain.2013.08.019. Epub 2013 Aug 22.

PMID:
23973358
17.

Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors.

Imbernon M, Whyte L, Diaz-Arteaga A, Russell WR, Moreno NR, Vazquez MJ, Gonzalez CR, Díaz-Ruiz A, Lopez M, Malagón MM, Ross RA, Dieguez C, Nogueiras R.

Mol Cell Endocrinol. 2014 Mar 5;383(1-2):159-69. doi: 10.1016/j.mce.2013.12.011. Epub 2013 Dec 27.

PMID:
24378736
18.

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Abood ME.

J Biol Chem. 2009 Oct 23;284(43):29817-27. doi: 10.1074/jbc.M109.050187. Epub 2009 Sep 1.

19.

Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): Possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1.

Yamashita A, Kumazawa T, Koga H, Suzuki N, Oka S, Sugiura T.

Biochim Biophys Acta. 2010 Jul;1801(7):711-20. doi: 10.1016/j.bbalip.2010.03.012. Epub 2010 Mar 30.

PMID:
20359546
20.

A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.

Kargl J, Brown AJ, Andersen L, Dorn G, Schicho R, Waldhoer M, Heinemann A.

J Pharmacol Exp Ther. 2013 Jul;346(1):54-66. doi: 10.1124/jpet.113.204180. Epub 2013 May 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk